However, a series of interesting anecdotal reports have demonstrated that immune therapy with ipilimumab (human anti-CTLA4 antibody) followed by radiation can lead to extensive tumor regression with increased tumor antigen specific responses. This evidence concerns the gene CTLA4 and neoplasm.